TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.40$ +0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Upstream Bio, Inc. (UPB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 281 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UPB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
117 245 233 482 456 421 391 354 318 281
117 243 227 479 454 418 389 352 316 280
26 110 47 33 326 71 45 72 102 97 79
110 110 236 221 470 431 394 372 342 295 261
0.2 0.9 1.1 1.2 1.7 2.6 0.7 0.7 1.0 2.2
240 -108 391 393 12 11 12 13 14 14 10
6.5 10 11 11 9.6 11 12 13 14 10.0
0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7
2.0 5.6 4.9 4.0 4.7 2.6 4.0 2.7 1.7 2.3
-123 108 -147 -160 470 446 409 379 340 304 271
-128 -154 -170 -191 -218 -258 -292 -334 -375 -415
36 36 51 51 51 51 54 54 54 54 54 55

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?